AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction - Analysis of the coronary artery bypass grafting patchtrial database
Authors: Argenziano, M Spotnitz, HM Whang, W Bigger, JT Parides, M Rose, EA
Citation: M. Argenziano et al., Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction - Analysis of the coronary artery bypass grafting patchtrial database, CIRCULATION, 100(19), 1999, pp. 119-124
Quantitative changes in T-cell populations after left ventricular assist device implantation - Relationship to T-cell apoptosis and soluble CD95
Authors: Ankersmit, HJ Edwards, NM Schuster, M John, R Kocher, A Rose, EA Oz, M Itescu, S
Citation: Hj. Ankersmit et al., Quantitative changes in T-cell populations after left ventricular assist device implantation - Relationship to T-cell apoptosis and soluble CD95, CIRCULATION, 100(19), 1999, pp. 211-215
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy
Authors: Helman, DN Morales, DLS Edwards, NM Mancini, DM Chen, JM Rose, EA Oz, MC
Citation: Dn. Helman et al., Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy, ANN THORAC, 68(4), 1999, pp. 1187-1194
Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films
Authors: Okuyama, N Wang, CY Rose, EA Rodgers, KE Pines, E diZerega, GS Oz, MC
Citation: N. Okuyama et al., Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films, ANN THORAC, 68(3), 1999, pp. 913-918
100 long-term implantable left ventricular assist devices: The Columbia Presbyterian Interim Experience
Authors: Sun, BC Catanese, KA Spanier, TB Flannery, MR Gardocki, MT Marcus, LS Levin, HR Rose, EA Oz, MC
Citation: Bc. Sun et al., 100 long-term implantable left ventricular assist devices: The Columbia Presbyterian Interim Experience, ANN THORAC, 68(2), 1999, pp. 688-694
The REMATCH trial: Rationale, design, and end points
Authors: Rose, EA Moskowitz, AJ Packer, M Sollano, JA Williams, DL Tierney, AR Heitjan, DF Meier, P Ascheim, DD Levitan, RG Weinberg, AD Stevenson, LW Shapiro, PA Lazar, RM Watson, JT Goldstein, DJ Gelijns, AC
Citation: Ea. Rose et al., The REMATCH trial: Rationale, design, and end points, ANN THORAC, 67(3), 1999, pp. 723-730
Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts
Authors: Suciu-Foca, N Ciubotariu, R Itescu, S Rose, EA Cortesini, R
Citation: N. Suciu-foca et al., Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts, TRANSPLAN P, 30(8), 1998, pp. 3999-4000
Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
Authors: Argenziano, M Chen, JM Choudhri, AF Cullinane, S Garfein, E Weinberg, AD Smith, CR Rose, EA Landry, DW Oz, MC
Citation: M. Argenziano et al., Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent, J THOR SURG, 116(6), 1998, pp. 973-980
Risultati: 1-25 | 26-33 |